Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteasome Endopeptidase Complex | 4 | 2023 | 1333 | 0.750 |
Why?
|
| Multiple Myeloma | 8 | 2023 | 5169 | 0.740 |
Why?
|
| Tubulin Modulators | 1 | 2020 | 110 | 0.720 |
Why?
|
| Tryptophan | 2 | 2019 | 478 | 0.700 |
Why?
|
| Amino Acids, Essential | 1 | 2018 | 24 | 0.650 |
Why?
|
| Electrochemical Techniques | 1 | 2018 | 98 | 0.620 |
Why?
|
| Tubulin | 1 | 2020 | 695 | 0.570 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2906 | 0.530 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 786 | 0.480 |
Why?
|
| Lymphoma, Follicular | 3 | 2022 | 435 | 0.460 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 1813 | 0.430 |
Why?
|
| Body Mass Index | 4 | 2021 | 12695 | 0.380 |
Why?
|
| Proteome | 1 | 2020 | 1790 | 0.360 |
Why?
|
| Obesity, Abdominal | 1 | 2013 | 361 | 0.360 |
Why?
|
| Waist Circumference | 1 | 2013 | 917 | 0.340 |
Why?
|
| Kynurenine | 2 | 2019 | 137 | 0.320 |
Why?
|
| Uric Acid | 1 | 2014 | 760 | 0.320 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 5163 | 0.310 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2022 | 1377 | 0.270 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2022 | 3557 | 0.260 |
Why?
|
| Antineoplastic Agents | 5 | 2020 | 13655 | 0.250 |
Why?
|
| Antigens, CD19 | 3 | 2022 | 379 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8425 | 0.240 |
Why?
|
| Dendritic Cells | 5 | 2022 | 2723 | 0.230 |
Why?
|
| Ubiquitin | 3 | 2023 | 849 | 0.220 |
Why?
|
| Population Surveillance | 1 | 2013 | 2616 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 2938 | 0.190 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 86 | 0.190 |
Why?
|
| Prader-Willi Syndrome | 1 | 2021 | 79 | 0.190 |
Why?
|
| China | 3 | 2022 | 2246 | 0.190 |
Why?
|
| Cell Proliferation | 6 | 2022 | 10472 | 0.180 |
Why?
|
| Caspases | 2 | 2020 | 928 | 0.180 |
Why?
|
| Killer Cells, Natural | 4 | 2022 | 2133 | 0.180 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2020 | 135 | 0.180 |
Why?
|
| Colchicine | 1 | 2020 | 242 | 0.170 |
Why?
|
| Diamond | 1 | 2018 | 13 | 0.160 |
Why?
|
| Crystallography, X-Ray | 2 | 2020 | 2014 | 0.160 |
Why?
|
| Boron | 1 | 2018 | 36 | 0.160 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2018 | 90 | 0.160 |
Why?
|
| Kynurenic Acid | 1 | 2018 | 45 | 0.160 |
Why?
|
| Chemical Fractionation | 1 | 2018 | 65 | 0.160 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2020 | 134 | 0.160 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2020 | 169 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 3 | 2021 | 6313 | 0.160 |
Why?
|
| Mice, SCID | 2 | 2020 | 2715 | 0.150 |
Why?
|
| Probiotics | 1 | 2021 | 351 | 0.150 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2020 | 233 | 0.150 |
Why?
|
| Limit of Detection | 1 | 2018 | 264 | 0.150 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2021 | 1820 | 0.140 |
Why?
|
| Quinazolines | 2 | 2022 | 1355 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2022 | 16665 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1835 | 0.140 |
Why?
|
| Electrodes | 1 | 2018 | 615 | 0.130 |
Why?
|
| Fluorescence | 1 | 2018 | 751 | 0.130 |
Why?
|
| Administration, Oral | 2 | 2020 | 3913 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 11695 | 0.130 |
Why?
|
| Cell Survival | 3 | 2020 | 5872 | 0.130 |
Why?
|
| Neoplasms | 2 | 2021 | 21596 | 0.120 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2022 | 1379 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 1574 | 0.120 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 930 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 1899 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 11472 | 0.120 |
Why?
|
| Myelopoiesis | 1 | 2014 | 131 | 0.120 |
Why?
|
| Serotonin | 1 | 2018 | 1024 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2020 | 1707 | 0.110 |
Why?
|
| Proteomics | 2 | 2023 | 3618 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15108 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 1327 | 0.110 |
Why?
|
| Cell Communication | 1 | 2020 | 1619 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2020 | 4013 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1515 | 0.100 |
Why?
|
| Binding Sites | 1 | 2020 | 6115 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2170 | 0.100 |
Why?
|
| Triglycerides | 1 | 2019 | 2450 | 0.100 |
Why?
|
| Apoptosis | 4 | 2022 | 9715 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2020 | 5454 | 0.090 |
Why?
|
| Mice | 7 | 2022 | 81045 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 2354 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2023 | 5019 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 2842 | 0.090 |
Why?
|
| Animals | 10 | 2022 | 168561 | 0.090 |
Why?
|
| Young Adult | 6 | 2021 | 56350 | 0.080 |
Why?
|
| alpha-Globins | 1 | 2008 | 17 | 0.080 |
Why?
|
| Survival Rate | 2 | 2020 | 12773 | 0.080 |
Why?
|
| HCT116 Cells | 2 | 2021 | 408 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5171 | 0.080 |
Why?
|
| Humans | 23 | 2023 | 742088 | 0.080 |
Why?
|
| Autophagy | 1 | 2016 | 1301 | 0.080 |
Why?
|
| Proteins | 1 | 2023 | 6096 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8300 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3504 | 0.070 |
Why?
|
| Prevalence | 2 | 2014 | 15194 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 4249 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 1656 | 0.070 |
Why?
|
| Reference Values | 1 | 2013 | 4982 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2014 | 3731 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 1 | 2008 | 894 | 0.060 |
Why?
|
| Zebrafish | 2 | 2014 | 2990 | 0.060 |
Why?
|
| Prognosis | 3 | 2020 | 29010 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2008 | 705 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 6347 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2022 | 3689 | 0.060 |
Why?
|
| Adolescent | 5 | 2021 | 85649 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 1372 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13921 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2022 | 1255 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14720 | 0.050 |
Why?
|
| Health Surveys | 1 | 2013 | 4030 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9639 | 0.050 |
Why?
|
| Male | 7 | 2022 | 349538 | 0.050 |
Why?
|
| Neutrophils | 1 | 2014 | 3711 | 0.050 |
Why?
|
| Rats | 1 | 2018 | 24265 | 0.050 |
Why?
|
| Adult | 6 | 2021 | 213712 | 0.050 |
Why?
|
| Female | 7 | 2021 | 379592 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 20928 | 0.050 |
Why?
|
| 5'-Nucleotidase | 1 | 2022 | 160 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2021 | 40955 | 0.050 |
Why?
|
| Middle Aged | 5 | 2020 | 213127 | 0.050 |
Why?
|
| Sex Factors | 1 | 2014 | 10392 | 0.040 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 10163 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2022 | 8436 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 352 | 0.040 |
Why?
|
| Depression | 1 | 2018 | 7733 | 0.040 |
Why?
|
| Half-Life | 1 | 2019 | 658 | 0.040 |
Why?
|
| Bleomycin | 1 | 2019 | 499 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 563 | 0.040 |
Why?
|
| Motor Skills | 1 | 2021 | 518 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2022 | 874 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2018 | 130 | 0.040 |
Why?
|
| Child | 3 | 2021 | 77478 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 3617 | 0.040 |
Why?
|
| Age Factors | 1 | 2014 | 18355 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13019 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2021 | 2335 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 57683 | 0.030 |
Why?
|
| Transcription Factor CHOP | 1 | 2016 | 73 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2020 | 1341 | 0.030 |
Why?
|
| Glycolysis | 1 | 2020 | 825 | 0.030 |
Why?
|
| Imidazoles | 1 | 2022 | 1205 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2019 | 23387 | 0.030 |
Why?
|
| Zebrafish Proteins | 2 | 2014 | 1004 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 2085 | 0.030 |
Why?
|
| Chloroquine | 1 | 2016 | 280 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 789 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2014 | 68 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2019 | 1725 | 0.030 |
Why?
|
| Vincristine | 1 | 2016 | 1036 | 0.030 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 451 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2022 | 4414 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3133 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 320 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 24913 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 694 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 72145 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1670 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 1791 | 0.030 |
Why?
|
| Prednisone | 1 | 2016 | 1567 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 5522 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2016 | 2236 | 0.020 |
Why?
|
| RNA Interference | 1 | 2019 | 2890 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2022 | 2933 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3564 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2016 | 2215 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2749 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2107 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2019 | 2941 | 0.020 |
Why?
|
| Aged | 3 | 2020 | 162944 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 5519 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3294 | 0.020 |
Why?
|
| beta-Globins | 1 | 2008 | 113 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2008 | 218 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40054 | 0.020 |
Why?
|
| Communication | 1 | 2021 | 3728 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 1581 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 2751 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 3199 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 504 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2008 | 572 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1799 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15994 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 1950 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9410 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 1546 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2088 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4751 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5180 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 12730 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 9826 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 77098 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 35070 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39004 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 5867 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 3518 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 7721 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13029 | 0.010 |
Why?
|
Concepts
(197)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_